DuPont Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Net Sales: $1.8 billion, up 4% year-over-year, driven by organic sales growth.

Operating EBITDA: $448 million, an 8% increase from the previous year, with a margin of 24.6%, reflecting an 80 basis point year-over-year improvement.

Adjusted EPS: $1.88, a 21% increase compared to the prior year.

Free Cash Flow: $326 million, with a conversion rate of 127%, exceeding the target of 90%.

Organic Sales Growth: 4% overall, with notable contributions from Healthcare, Water Technologies, and Diversified Industrials.

2Strategic Updates and Business Highlights

DuPont is focusing on operational excellence, innovation, and commercial discipline to drive sustainable performance.

The company launched a $250 million share repurchase program and completed a reverse stock split to align performance metrics with industrial peers.

Significant advancements in innovation were highlighted, including new products in lithium extraction and healthcare applications.

The company is leveraging AI to enhance sales processes, achieving a 30% win rate on new opportunities, which is above historical benchmarks.

3Forward Guidance and Outlook

DuPont raised its full-year 2026 guidance for organic sales growth to slightly above 4%, with operating EBITDA expected to reach $1.76 billion.

For Q3 2026, net sales are projected at $1.835 billion, with operating EBITDA of $448 million and adjusted EPS expected between $1.80 and $1.90.

The company anticipates continued strength in healthcare, industrial water, and aerospace markets, with organic growth expectations of 6% year-over-year in the second half.

4Bad News, Challenges, or Points of Concern

The Water segment faced challenges due to geopolitical issues in the Middle East, impacting growth expectations and leading to a downward revision for the segment's full-year outlook.

Margins in the Healthcare & Water Technologies segment contracted by 30 basis points, attributed to a less favorable product mix and growth investments.

There are ongoing inflationary pressures from oil and gas, which are expected to impact margins in the second half of the year.

5Notable Q&A Insights

Innovation Contribution: The vitality index for innovation is at 35%, with a focus on maintaining a balance between growth and replacement products.

Cost of Poor Quality: Currently at 4% of sales, below the benchmark of 5%, with plans to reduce this further through operational excellence initiatives.

M&A Pipeline: DuPont has a robust M&A pipeline, particularly in the Water and Healthcare sectors, with over $1 billion available for acquisitions.

Sales Strategy Changes: Compensation plans for the sales force are being revised to incentivize growth more effectively, transitioning to a commission-based structure in 2027.

Market Dynamics: The company is optimistic about the EV battery market, projecting significant growth in this sector, which is currently a $70 million revenue stream. Overall, DuPont's Q2 2026 results reflect a strong performance driven by strategic initiatives, although challenges remain in specific segments due to external factors. The company is well-positioned for continued growth with an optimistic outlook for the second half of the year.